Ping Ou Huang

Dr. Ping Ou Huang


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Gene
Verified
Journal Article
Closed access
ZZZiyu Zhang
Ziyu Zhang
KTKaijia Tu
Kaijia Tu
FLFaying Liu
Faying Liu
MLMeirong Liang
Meirong Liang
KYKaihui Yu
Kaihui Yu
YZYang Zou
Yang Zou

6 February 2012 in Gynecological Endocrinology
Verified
Journal Article
Closed access
LWLiqun Wang
Liqun Wang
HHHuang Huang
Huang Huang
DLDan Liu
Dan Liu
SFShufeng Fang
Shufeng Fang
YXYan Xian
Yan Xian
MHMing He
Ming He
Uterine leiomyomas represents a major public health problem. Despite their prevalence, the causation and pathogenesis of leiomyomas are poorly understood. A broad range of organisms and tissues contain 14-3-3 proteins which have been associated with the pathogenesis of many diseases through participating in signal transduction pathways. This study was designed to evaluate which 14-3-3 isoforms might be optimal targets in leiomyomas, and to further explore their relationship with estrogen and progesterone receptor (ER and PR). Paired samples of leiomyoma and adjacent myometrium were obtained from 80 subjects who had surgical excision of uterine leiomyomas. The expression of 14-3-3 isoforms was detected by Western bolt and RT-PCR, and their relationship with ER and PR was analysed by immunohistochemistry. The expressions of 14-3-3σ had decreased significantly in leiomyoma compared with that in normal myometrium and was negatively correlated with ER and PR by immunohistochemistry. The down-regulation of 14-3-3σ in leiomyoma suggests that 14-3-3σ may play a role in tumorigenesis, and that its mechanism may be involved in the up-regulation of ER and PR.

1 August 2019 in Gene
Verified
Journal Article
Closed access
YLYou Li
You Li
QZQuan Zhang
Quan Zhang
FLFaying Liu
Faying Liu
ZZZiyu Zhang
Ziyu Zhang
YZYang Zou
Yang Zou
PHPing Ou Huang
Ping Ou Huang

4 April 2022 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
ZZZiyu Zhang
Ziyu Zhang
YWYaoqing Wang
Yaoqing Wang
LZLiqin Zeng
Liqin Zeng
KYKaihui Yu
Kaihui Yu
YWYuanqin Wang
Yuanqin Wang
PHPing Ou Huang
Ping Ou Huang
Background: Our previous two-dimensional electrophoresis experiment showed that the expression of LASP1 in patients with endometriosis was significantly higher than that of control endometrium. However, the molecular mechanism by which LASP1 is regulated in endometriosis/adenomyosis is unknown. Methods: Herein, qPCR was performed to analyze the expression levels of LASP1 and miR-218-5p between endometriosis (Ems) cells and control cells. Fluorescence in situ hybridization was carried out to measure the expression level of miR-218-5p in ectopic endometrium versus normal endometrium. After miR-218-5p mimic or inhibitor were transfected, the transwell experiment was carried out to see the effect of miR-218-5p on the migration of endometrial stromal cells (ESCs). EdU was used to measure cell proliferation rate. Dual-luciferase reporter assay was used to verify the binding of hsa-miR-218-5p to the 3’UTR of LASP1. Western blot and immunofluorescence analysis were carried out to identify the protein expression pattern of LASP1 and EMT markers in endometrial tissue. Results: The miR-218-5p is mainly secreted from blood vessels and expressed in the muscle layer around the endometrium, which inhibits the expression level of LASP1 by binding the 3’UTR region of LASP1 in normal ESCs. Overexpression of miR-218-5p impedes the epithelial-to-mesenchymal transition (EMT) and prevents the migration of ESCs and the expression of Vimentin in Ems. Conclusions: Our findings revealed that miR-218-5p in endometrial microenvironment prevents the migration of ectopic endometrial stromal cells by inhibiting LASP1.

11 December 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
ZZZiyu Zhang
Ziyu Zhang
YZYang Zou
Yang Zou
MLMeirong Liang
Meirong Liang
YCYuanting Chen
Yuanting Chen
YLYong Luo
Yong Luo
PHPing Ou Huang
Ping Ou Huang
Suppressor of fused (Sufu) promotes epithelial-mesenchymal transition (EMT) in cervical squamous cell carcinoma Suppressor of fused (Sufu) promotes epithelial-mesenchymal transition (EMT) in cervical squamous cell carcinoma

1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
ZZZiyu Zhang
Ziyu Zhang
FLFaying Liu
Faying Liu
YXYunYun Xu
YunYun Xu
HHHuang Huang
Huang Huang
YZYang Zou
Yang Zou
PHPing Ou Huang
Ping Ou Huang
Endometriosis is still a major problem in obstetrics and gynecology. While GZFLW (Gui Zhi Fu Ling Wan) has been originally used for treating gynecological diseases, however, the molecular mechanism that GZFLW acts on endometriosis is not clear. To investigate the molecular mechanism that GZFLW plays role on endometriosis, iTRAQ (isobaric tags for relative and absolute quantification) proteomics and human endometrial stromal cells (Y14) obtained from a patient with endometriosis were used in in vitro study. Our results demonstrated that GZFLW decreased Y14 cells proliferation while increased cells apoptosis. The differential expression protein VPS53 (Vacuolar protein sorting 53 homolog) was predicted by iTRAQ coupled LC‐MS/MS and further identified by western blot. Besides, GZFLW induced VPS53 protein level by promoting its stabilization. Our findings highlight a novel role for VPS53 in gynecology and provide a potent therapeutic strategy against endometriosis.